FDA
- Status: approved
🇺🇸 Erythromycin 4% topical gel formulation in United States
Erythromycin 4% topical gel formulation (Erythromycin 4% topical gel formulation) regulatory status in United States.
Marketing authorisation
Erythromycin 4% topical gel formulation in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Erythromycin 4% topical gel formulation approved in United States?
Yes. FDA has authorised it.
Who is the marketing authorisation holder for Erythromycin 4% topical gel formulation in United States?
Centre for Human Drug Research, Netherlands is the originator. The local marketing authorisation holder may differ — check the official source linked above.